Orlistat
| Use attributes for filter ! | |
| Molar mass | 495. 735 g/mol |
|---|---|
| CAS ID | 96829-58-2 |
| Formula | C29H53NO5 |
| Other names | tetrahydrolipstatin |
| Trade name | Xenical, Alli |
| Elimination half-life | 1 to 2 hours |
| Date of Reg. | |
| Date of Upd. | |
| ID | 2951031 |
About Orlistat
Orlistat is a drug designed to treat obesity. It is marketed as a prescription drug under the trade name Xenical by Roche in most countries, and is sold over-the-counter as Alli by GlaxoSmithKline in the United Kingdom and the United States.
Weight loss jab recommended on NHS
Adults struggling with their Weight could soon be offered a weekly injection to help shed unhealthy fat.
The Treatment , semaglutide, branded Wegovy, makes people feel fuller, so they eat less, and not as hungry.
, used alongside a healthy diet and exercise, it helped obese people lose a 10th of their body Weight - About Two Stone (13kg) on average.
And The National Institute for Health and Care Excellence is recommending it should be made available on the NHS.
NICE's draft guidelines for England and Wales, Not Yet fully approved, say it should be prescribed:
People would inject themselves, using pre-filled pens.
Obese people should speak to their GP About losing Weight safely.
Some manage it through diet and exercise Alone .
:
Obesity affects About one in four adults in the UK and increases The Risk of other serious health conditions.
In 2018-19, 11,117 were directly attributable to obesity.
Helen Knight, from NICE, said: " We know that management of overweight and obesity is one of the biggest challenges our health service is facing.
" It is a lifelong condition that needs medical intervention, has psychological and physical effects, and can affect quality of life. "
Source of news: bbc.com
